Jazz Pharmaceuticals PLC (JAZZ)
Payables turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of revenue (ttm) | US$ in thousands | 756,666 | 886,749 | 877,291 | 709,703 | 587,130 | 495,698 | 527,206 | 553,877 | 540,517 | 509,306 | 520,869 | 515,855 | 440,760 | 354,764 | 251,635 | 160,449 | 148,917 | 134,108 | 123,413 | 123,081 |
| Payables | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Payables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
Payables turnover = Cost of revenue (ttm) ÷ Payables
= $756,666K ÷ $—K
= —
The payables turnover ratio for Jazz Pharmaceuticals PLC is not available for the period from March 31, 2020, through December 31, 2024, as indicated by the data provided. The payables turnover ratio is a financial metric that measures how efficiently a company manages its outstanding payables by comparing the purchases made on credit to the average accounts payable balance. A higher payables turnover ratio usually indicates that the company is paying its suppliers more quickly, which can be a sign of good financial health and strong working capital management. Conversely, a lower ratio may suggest that the company is taking longer to pay its suppliers, which could potentially strain relationships or indicate liquidity issues. Without the specific values for the payables turnover ratio for Jazz Pharmaceuticals PLC, it is not possible to analyze the company's payables management efficiency or draw any conclusions regarding its financial performance in this aspect.
Peer comparison
Dec 31, 2024